Diaceutics PLC - Belfast-based testing laboratories company - Wins a three-year enterprise contract with an unnamed ‘top 10 global pharmaceutical company’ based in the US. Says the contract will bring in $10.1 million in revenue over its term, with options to ‘significantly’ increase its scope and value. Revenue will be recognised monthly, with immediate effect. Says revenue will be recognised on a monthly basis. It will deliver a range of subscription data services via its DXRX platform.

Chief Innovation Officer Ryan Keeling says: ‘The strength of our growing pipeline of new enterprise-level contracts highlights the progress made in becoming the primary commercialisation partner for pharma or biotech companies launching a new precision medicine.’

Current stock price: 91.50 pence each, up 14% on Monday morning in London

12-month change: down 17%

Copyright 2023 Alliance News Ltd. All Rights Reserved.